Tetrahydroisoquinoline analogs useful as growth hormone secretagogues

Details for Australian Patent Application No. 2001259592 (hide)

Owner Bristol-Myers Squibb Company

Inventors Tino, Joseph A.; Li, James J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001259592

PCT Pub. Number WO01/85695

Priority 60203335 11.05.00 US

Filing date 7 May 2001

Wipo publication date 20 November 2001

Acceptance publication date 24 February 2005

International Classifications

C07D 217/26 Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 031/472 - Non-condensed isoquinolines, e.g. papaverine

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07K 005/06 Peptides having up to four amino acids in a fully defined sequence

C07D 223/16 Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

C07D 209/44 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61P 003/00 Drugs for disorders of the metabolism

Event Publications

24 February 2005 Application Accepted

  Published as AU-B-2001259592

23 June 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001259593

2001259591-SYSTEM FOR ANSWERING NATURAL LANGUAGE QUESTIONS